BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bishop JR, Zhang L, Lizano P. Inflammation Subtypes and Translating Inflammation-Related Genetic Findings in Schizophrenia and Related Psychoses: A Perspective on Pathways for Treatment Stratification and Novel Therapies. Harv Rev Psychiatry 2022;30:59-70. [PMID: 34995036 DOI: 10.1097/HRP.0000000000000321] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Strube W, Aksar A, Bauer I, Barbosa S, Benros M, Blankenstein C, Campana M, Davidovic L, Glaichenhaus N, Falkai P, Görlitz T, Hansbauer M, Heilig D, Khalfallah O, Leboyer M, Martinuzzi E, Mayer S, Moussiopoulou J, Papazova I, Perić N, Wagner E, Schneider-axmann T, Simon J, Hasan A. Effects of add-on Celecoxib treatment on patients with schizophrenia spectrum disorders and inflammatory cytokine profile trial (TargetFlame): study design and methodology of a multicentre randomized, placebo-controlled trial. J Neural Transm 2022. [DOI: 10.1007/s00702-022-02566-6] [Reference Citation Analysis]
2 Aichholzer M, Gangadin SS, Sommer IE, Wijkhuis A, de Witte LD, Kahn RS, Bahn S, Drexhage HA, Schiweck C. Inflammatory monocyte gene signature predicts beneficial within group effect of simvastatin in patients with schizophrenia spectrum disorders in a secondary analysis of a randomized controlled trial. Brain, Behavior, & Immunity - Health 2022. [DOI: 10.1016/j.bbih.2022.100551] [Reference Citation Analysis]
3 Park JH. Potential Inflammatory Biomarker in Patients with Attention Deficit Hyperactivity Disorder. IJMS 2022;23:13054. [DOI: 10.3390/ijms232113054] [Reference Citation Analysis]
4 Eum S, Hill SK, Bishop JR. Considering medication exposure in genomic association studies of cognition in psychotic disorders. Pharmacogenomics 2022;23:791-806. [PMID: 36102182 DOI: 10.2217/pgs-2022-0070] [Reference Citation Analysis]
5 Sæther LS, Ueland T, Haatveit B, Maglanoc LA, Szabo A, Djurovic S, Aukrust P, Roelfs D, Mohn C, Greenwood Ormerod MBE, Lagerberg TV, Steen NE, Melle I, Andreassen OA, Ueland T. Inflammation and cognition in severe mental illness: Patterns of covariation and subgroups.. [DOI: 10.1101/2022.08.25.22279209] [Reference Citation Analysis]
6 Bioque M, Catarina Matias-Martins A, Llorca-Bofí V, Mezquida G, Cuesta MJ, Vieta E, Amoretti S, Lobo A, González-Pinto A, Moreno C, Roldán A, Martinez-Aran A, Baeza I, Bergé D, García-Rizo C, Mas Herrero S, Bernardo M; 2EPs GROUP . Neutrophil to Lymphocyte Ratio in Patients With a First Episode of Psychosis: A Two-Year Longitudinal Follow-up Study. Schizophr Bull 2022:sbac089. [PMID: 35876785 DOI: 10.1093/schbul/sbac089] [Reference Citation Analysis]
7 Zhang L, Lizano P, Guo B, Xu Y, Rubin LH, Hill SK, Alliey-rodriguez N, Lee AM, Wu B, Keedy SK, Tamminga CA, Pearlson GD, Clementz BA, Keshavan MS, Gershon ES, Sweeney JA, Bishop JR. Inflammation subtypes in psychosis and their relationships with genetic risk for psychiatric and cardiometabolic disorders. Brain, Behavior, & Immunity - Health 2022;22:100459. [DOI: 10.1016/j.bbih.2022.100459] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Ermakov EA, Melamud MM, Buneva VN, Ivanova SA. Immune System Abnormalities in Schizophrenia: An Integrative View and Translational Perspectives. Front Psychiatry 2022;13:880568. [PMID: 35546942 DOI: 10.3389/fpsyt.2022.880568] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Türközer HB, Lizano P, Adhan I, Ivleva EI, Lutz O, Zeng V, Zeng A, Raymond N, Bannai D, Lee A, Bishop JR, Clementz BA, Pearlson GD, Sweeney JA, Gershon E, Keshavan MS, Tamminga CA. Regional and Sex-specific Alterations in the Visual Cortex of Individuals with Psychosis Spectrum Disorders. Biological Psychiatry 2022. [DOI: 10.1016/j.biopsych.2022.03.023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Morris G, Sominsky L, Walder KR, Berk M, Marx W, Carvalho AF, Bortolasci CC, Maes M, Puri BK. Inflammation and Nitro-oxidative Stress as Drivers of Endocannabinoid System Aberrations in Mood Disorders and Schizophrenia. Mol Neurobiol 2022. [PMID: 35347586 DOI: 10.1007/s12035-022-02800-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
11 Fendrich SJ, Koralnik LR, Bonner M, Goetz D, Joe P, Lee J, Mueller B, Robinson-papp J, Gonen O, Clemente JC, Malaspina D. Patient-reported exposures and outcomes link the gut-brain axis and inflammatory pathways to specific symptoms of severe mental illness. Psychiatry Research 2022. [DOI: 10.1016/j.psychres.2022.114526] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Lizano P. Introduction. Harv Rev Psychiatry 2022;30:1-3. [PMID: 34995030 DOI: 10.1097/HRP.0000000000000324] [Reference Citation Analysis]